A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).
Clinical trial NCT06067828 · COMPLETED
Trial details
- NCT number
- NCT06067828
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2026-01-22
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.